These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21659402)

  • 1. Latest developments in the treatment of melanoma: 'a penicillin moment for cancer'?
    Retsas S
    J R Soc Med; 2011 Jun; 104(6):269-72. PubMed ID: 21659402
    [No Abstract]   [Full Text] [Related]  

  • 2. Aflibercept, ipilimumab, and vemurafenib.
    Hussar DA; Au AY
    J Am Pharm Assoc (2003); 2012; 52(2):291-4. PubMed ID: 22370387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New targeted therapies in melanoma.
    Kudchadkar RR; Gonzalez R; Lewis K
    Cancer Control; 2013 Oct; 20(4):282-8. PubMed ID: 24077404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment for melanoma: progress, but who pays?
    Kefford RF
    Med J Aust; 2012 Aug; 197(4):198-9. PubMed ID: 22900855
    [No Abstract]   [Full Text] [Related]  

  • 6. Vemurafenib for the treatment of BRAF mutant metastatic melanoma.
    Martin-Liberal J; Larkin J
    Future Oncol; 2015; 11(4):579-89. PubMed ID: 25686114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of melanoma.
    Lacy KE; Karagiannis SN; Nestle FO
    Clin Med (Lond); 2012 Apr; 12(2):168-71. PubMed ID: 22586796
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecularly targeted therapies for melanoma.
    Liu LS; Colegio OR
    Int J Dermatol; 2013 May; 52(5):523-30. PubMed ID: 23590367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances and perspectives in the treatment of advanced melanoma.
    Livingstone E; Zimmer L; Vaubel J; Schadendorf D
    J Dtsch Dermatol Ges; 2012 May; 10(5):319-25. PubMed ID: 22432863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling Comparative Efficacy of Drugs with Different Survival Profiles: Ipilimumab, Vemurafenib and Dacarbazine in Advanced Melanoma.
    Lee D; Porter J; Hertel N; Hatswell AJ; Briggs A
    BioDrugs; 2016 Aug; 30(4):307-19. PubMed ID: 27177756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New challenges in endpoints for drug development in advanced melanoma.
    Ribas A; Hersey P; Middleton MR; Gogas H; Flaherty KT; Sondak VK; Kirkwood JM
    Clin Cancer Res; 2012 Jan; 18(2):336-41. PubMed ID: 22142824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic therapy for metastatic melanoma in 2012: dawn of a new era.
    Bhatia S; Thompson JA
    J Natl Compr Canc Netw; 2012 Mar; 10(3):403-12. PubMed ID: 22393198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipilimumab and vemurafenib: two different routes for targeting melanoma.
    Burgeiro A; Mollinedo F; Oliveira PJ
    Curr Cancer Drug Targets; 2013 Oct; 13(8):879-94. PubMed ID: 23862981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the management of melanoma: targeted therapy, immunotherapy and future directions.
    Dean E; Lorigan P
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1437-48. PubMed ID: 23249108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vemurafenib and ipilimumab: new agents for metastatic melanoma.
    Banaszynski M; Kolesar JM
    Am J Health Syst Pharm; 2013 Jul; 70(14):1205-10. PubMed ID: 23820456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vemurafenib for the treatment of melanoma.
    Jordan EJ; Kelly CM
    Expert Opin Pharmacother; 2012 Dec; 13(17):2533-43. PubMed ID: 23094782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment patterns in advanced melanoma: findings from a survey of European oncologists.
    Jones C; Zhao Z; Barber B; Bagijn M; Corrie P; Saltman D
    Eur J Cancer Care (Engl); 2015 Nov; 24(6):862-6. PubMed ID: 25988349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous melanoma: new advances in treatment.
    Foletto MC; Haas SE
    An Bras Dermatol; 2014; 89(2):301-10. PubMed ID: 24770508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Major therapeutic advances in the treatment of metastatic melanoma].
    Mateus C; Robert C
    Bull Cancer; 2012 Jun; 99(6):619-25. PubMed ID: 22652330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.
    Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C
    Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.